Superiority of [
Masaoka-Koga
PET/CT
Thymic epithelial tumours
WHO classification
[18F]FDG
[68Ga]Ga-DOTA-FAPI-04
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
19
03
2023
accepted:
04
06
2023
medline:
23
10
2023
pubmed:
15
6
2023
entrez:
14
6
2023
Statut:
ppublish
Résumé
The purpose of this study is to compare the ability of [ From April 2021 to November 2022, participants with suspected TETs confirmed by histopathology or follow-up imaging were prospectively analysed. All participants underwent [ Fifty-seven participants were included. [ [ ChiCTR2000038080, registration date 2020-09-09, https://www.chictr.org.cn/com/25/showproj.aspx?proj=61192.
Identifiants
pubmed: 37316675
doi: 10.1007/s00259-023-06294-1
pii: 10.1007/s00259-023-06294-1
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
68Ga-FAPI
0
Gallium Radioisotopes
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Quinolines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3414-3424Subventions
Organisme : National Natural Science Foundation of China
ID : (Grants 81871387
Organisme : National Natural Science Foundation of China
ID : 81671733
Organisme : National Natural Science Foundation of China
ID : 81871386)
Organisme : Natural Science Foundation of Beijing Municipality
ID : (Grants 7202027)
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Shin DW, Cho JH, Ha J, Jung KW. Trends in incidence and survival of patients with thymic epithelial tumor in a high-incidence Asian country: analysis of the Korean Central Cancer Registry 1999 to 2017. J Thorac Oncol. 2022;17:827–37. https://doi.org/10.1016/j.jtho.2022.02.001 .
doi: 10.1016/j.jtho.2022.02.001
pubmed: 35158083
Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022;17:200–13. https://doi.org/10.1016/j.jtho.2021.10.010 .
doi: 10.1016/j.jtho.2021.10.010
pubmed: 34695605
Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran C, Zakowski MF, et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer. 2008;112:2780–8. https://doi.org/10.1002/cncr.23492 .
doi: 10.1002/cncr.23492
pubmed: 18442102
Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol. 2011;6:S1710–6. https://doi.org/10.1097/JTO.0b013e31821e8cff .
doi: 10.1097/JTO.0b013e31821e8cff
pubmed: 21847052
Lee HS, Kim ST, Lee J, Choi YS, Han JH, Ahn YC, et al. A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management. Br J Cancer. 2007;97:22–8. https://doi.org/10.1038/sj.bjc.6603833 .
doi: 10.1038/sj.bjc.6603833
pubmed: 17592498
pmcid: 2359672
Expert Panel on Thoracic I, Ackman JB, Chung JH, Walker CM, Bang TJ, Carter BW, et al. ACR appropriateness criteria(R) imaging of mediastinal masses. J Am Coll Radiol. 2021;18:S37-S51. https://doi.org/10.1016/j.jacr.2021.01.007 .
Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, et al. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol. 2011;6:1274–81. https://doi.org/10.1097/JTO.0b013e31821c4203 .
doi: 10.1097/JTO.0b013e31821c4203
pubmed: 21623235
Priola AM, Priola SM, Giraudo MT, Gned D, Fornari A, Ferrero B, et al. Diffusion-weighted magnetic resonance imaging of thymoma: ability of the apparent diffusion coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival. Eur Radiol. 2016;26:2126–38. https://doi.org/10.1007/s00330-015-4031-6 .
doi: 10.1007/s00330-015-4031-6
pubmed: 26427698
Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA.
pubmed: 17015898
Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, et al. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Lung Cancer. 2011;74:239–43. https://doi.org/10.1016/j.lungcan.2011.02.018 .
doi: 10.1016/j.lungcan.2011.02.018
pubmed: 21439670
Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, et al. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. J Thorac Oncol. 2013;8:502–10. https://doi.org/10.1097/JTO.0b013e3182835549 .
doi: 10.1097/JTO.0b013e3182835549
pubmed: 23446204
Ito T, Suzuki H, Sakairi Y, Wada H, Nakajima T, Yoshino I.
doi: 10.1007/s11748-020-01439-7
pubmed: 32734427
Tatematsu T, Okuda K, Saito Y, Oda R, Sakane T, Yokota K, et al. The usefulness of fluorodeoxyglucose-positron emission tomography as a preoperative diagnostic tool for thymic epithelial tumors. Gland Surg. 2021;10:690–6. https://doi.org/10.21037/gs-20-718 .
Han S, Kim YI, Oh JS, Seo SY, Park MJ, Lee GD, et al. Diagnostic and prognostic values of 2-[
doi: 10.1007/s00330-021-08230-z
pubmed: 34448035
Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18:99–115. https://doi.org/10.1038/s41573-018-0004-1 .
doi: 10.1038/s41573-018-0004-1
Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415–22. https://doi.org/10.2967/jnumed.118.210443 .
doi: 10.2967/jnumed.118.210443
pubmed: 29626119
Zhou X, Wang S, Xu X, Meng X, Zhang H, Zhang A, et al. Higher accuracy of [
doi: 10.1007/s00259-022-05818-5
pubmed: 35543731
Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [
doi: 10.1007/s00259-020-04769-z
pubmed: 32222810
Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al.
doi: 10.2967/jnumed.119.227967
pubmed: 30954939
pmcid: 6581228
Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13:1736–41. https://doi.org/10.1158/1078-0432.Ccr-06-1746 .
doi: 10.1158/1078-0432.Ccr-06-1746
pubmed: 17363526
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (Oxford, England:1990). 2009;45:228–47. https://doi.org/10.1016/j.ejca.2008.10.026 .
Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, et al. The IASLC/ITMIG thymic epithelial tumors staging project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S81–7. https://doi.org/10.1097/jto.0000000000000291 .
doi: 10.1097/jto.0000000000000291
pubmed: 25396316
Bayman EO, Dexter F. Multicollinearity in logistic regression models. Anesth Analg. 2021;133:362–5. https://doi.org/10.1213/ane.0000000000005593 .
doi: 10.1213/ane.0000000000005593
pubmed: 34257197
Obuchowski NA, McClish DK. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med. 1997;16:1529–42. https://doi.org/10.1002/(sici)1097-0258(19970715)16:13%3c1529::aid-sim565%3e3.0.co;2-h .
doi: 10.1002/(sici)1097-0258(19970715)16:13<1529::aid-sim565>3.0.co;2-h
pubmed: 9249923
NCCN Clinical Practice Guidelines in Oncology. Thymomas and thymic carcinomas version 1.2023. https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf . Published December 15, 2022. Accessed 17 April 2023.
Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1alpha, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Eur J Cardiothorac Surg. 2013;44:e105–12. https://doi.org/10.1093/ejcts/ezt263 .
doi: 10.1093/ejcts/ezt263
pubmed: 23674658
Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, et al.
doi: 10.1016/j.ejrad.2010.08.010
pubmed: 20810231
Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18:70. https://doi.org/10.1186/s12943-019-0994-2 .
doi: 10.1186/s12943-019-0994-2
pubmed: 30927908
pmcid: 6441236
Wu Z, Xue S, Zheng B, Ye R, Xu G, Zhang S, et al. Expression and significance of c-kit and epithelial-mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs). J Thorac Dis. 2019;11:4602–12. https://doi.org/10.21037/jtd.2019.10.56 .
Minami K, Jimbo N, Tanaka Y, Uchida T, Okamoto T, Shimizu N, et al. Fibrous bands associated with higher Masaoka stage and poor recurrence-free survival in patients with thymoma. Thorac Cancer. 2021;12:349–56. https://doi.org/10.1111/1759-7714.13755 .
doi: 10.1111/1759-7714.13755
pubmed: 33236521
Barrio JR, Huang SC, Satyamurthy N, Scafoglio CS, Yu AS, Alavi A, et al. Does 2-FDG PET accurately reflect quantitative in vivo glucose utilization? J Nucl Med. 2020;61:931–7. https://doi.org/10.2967/jnumed.119.237446 .
doi: 10.2967/jnumed.119.237446
pubmed: 31676728
pmcid: 7818046
Meyer HJ, Wienke A, Surov A. Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. PLoS ONE. 2019;14:e0217781. https://doi.org/10.1371/journal.pone.0217781 .
Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, et al. Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT in the evaluation of advanced lung cancer. Radiology. 2022;303:191–9. https://doi.org/10.1148/radiol.211424 .
doi: 10.1148/radiol.211424
pubmed: 34981976
Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243:137–47. https://doi.org/10.1002/path.4942 .
doi: 10.1002/path.4942
pubmed: 28722107